These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39220134)

  • 1. Retraction: Downregulation of MicroRNA-449 Promotes Migration and Invasion of Breast Cancer Cells by Targeting Tumor Protein D52 (TPD52).
    Oncology Research Editorial Office
    Oncol Res; 2024; 32(9):1525. PubMed ID: 39220134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of MicroRNA-449 Promotes Migration and Invasion of Breast Cancer Cells by Targeting Tumor Protein D52 (TPD52).
    Zhang Z; Wang J; Gao R; Yang X; Zhang Y; Li J; Zhang J; Zhao X; Xi C; Lu X
    Oncol Res; 2017 May; 25(5):753-761. PubMed ID: 27983918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor protein D52 promotes breast cancer proliferation and migration via the long non-coding RNA NEAT1/microRNA-218-5p axis.
    Ren J; Chen Y; Kong W; Li Y; Lu F
    Ann Transl Med; 2021 Jun; 9(12):1008. PubMed ID: 34277808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Star-PAP regulates tumor protein D52 through modulating miR-449a/34a in breast cancer.
    Duan A; Kong L; An T; Zhou H; Yu C; Li Y
    Biol Open; 2019 Nov; 8(11):. PubMed ID: 31649118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
    Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
    Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-1323 downregulation promotes migration and invasion of breast cancer cells by targeting tumour protein D52.
    Xu Y; Liu M
    J Biochem; 2020 Jul; 168(1):83-91. PubMed ID: 32211853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.
    Yin W; Shi L; Mao Y
    J Biochem; 2019 Nov; 166(5):433-440. PubMed ID: 31350893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-379 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by targeting tumor protein D52.
    Zhao X; Chu J
    Exp Ther Med; 2018 Aug; 16(2):1232-1240. PubMed ID: 30116374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-103a-3p Suppresses Cell Proliferation and Invasion by Targeting Tumor Protein D52 in Prostate Cancer.
    Ge J; Mao L; Xu W; Fang W; Wang N; Ye D; Dong Z; Guan H; Guan C
    J Invest Surg; 2021 Sep; 34(9):984-992. PubMed ID: 32166986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor protein D52 (isoform 3) interacts with and promotes peroxidase activity of Peroxiredoxin 1 in prostate cancer cells implicated in cell growth and migration.
    Dasari C; Reddy KRK; Natani S; Murthy TRL; Bhukya S; Ummanni R
    Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1298-1309. PubMed ID: 30981892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
    Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
    Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-κB transactivation in LNCaP cells.
    Dasari C; Yaghnam DP; Walther R; Ummanni R
    Tumour Biol; 2017 May; 39(5):1010428317698382. PubMed ID: 28466782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.
    Ummanni R; Teller S; Junker H; Zimmermann U; Venz S; Scharf C; Giebel J; Walther R
    FEBS J; 2008 Nov; 275(22):5703-13. PubMed ID: 18959755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52.
    Shehata M; Bièche I; Boutros R; Weidenhofer J; Fanayan S; Spalding L; Zeps N; Byth K; Bright RK; Lidereau R; Byrne JA
    Clin Cancer Res; 2008 Aug; 14(16):5050-60. PubMed ID: 18698023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?
    Byrne JA; Frost S; Chen Y; Bright RK
    Tumour Biol; 2014 Aug; 35(8):7369-82. PubMed ID: 24798974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.
    Zhang H; Li M; Zhang J; Shen Y; Gui Q
    Drug Des Devel Ther; 2021; 15():1835-1849. PubMed ID: 33976535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor protein D52 (TPD52) affects cancer cell metabolism by negatively regulating AMPK.
    Chen Y; Peng C; Tan W; Yu J; Zayas J; Peng Y; Lou Z; Pei H; Wang L
    Cancer Med; 2023 Jan; 12(1):488-499. PubMed ID: 35666017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor protein D52 represents a negative regulator of ATM protein levels.
    Chen Y; Kamili A; Hardy JR; Groblewski GE; Khanna KK; Byrne JA
    Cell Cycle; 2013 Sep; 12(18):3083-97. PubMed ID: 23974097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_0084927 Regulates Cervical Cancer Advancement via Regulation of the miR-634/TPD52 Axis.
    Shi P; Zhang X; Lou C; Xue Y; Guo R; Chen S
    Cancer Manag Res; 2020; 12():9435-9448. PubMed ID: 33061631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis.
    Li J; Li Y; Liu H; Liu Y; Cui B
    PLoS One; 2017; 12(5):e0178515. PubMed ID: 28562687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.